硼替佐米诱导的肺毒性：一例病例报告及文献综述
Bortezomib-Induced Pulmonary Toxicity: A Case Report and Review of Literature.
作者信息
Kharel Prakash, Uprety Deekchha, Chandra Abhinav B, Hu Yirui, Belur Anuradha Avinash, Dhakal Ajay
机构信息
Department of Hospital Medicine, Geisinger Medical Center, 100 N Academy Ave., Danville, PA 17821, USA.
Renal Division, Brigham and Women's Hospital, Boston, MA, USA.
出版信息
Case Rep Med. 2018 Nov 25;2018:2913124. doi: 10.1155/2018/2913124. eCollection 2018.
Bortezomib, a proteasome inhibitor, is an established therapy against multiple myeloma. Bortezomib-induced lung injury, although not appreciated during the introductory time of the medication, has now been highlighted in multiple case reports. The objective of this study is to report a case of bortezomib-induced lung injury, review current literature, and perform exploratory analysis.
硼替佐米，一种蛋白酶体抑制剂，是一种已被认可的治疗多发性骨髓瘤的药物。硼替佐米引起的肺损伤，尽管在该药物引入初期未被重视，但现在已在多篇病例报告中被强调。本研究的目的是报告一例硼替佐米引起的肺损伤病例，回顾当前文献，并进行探索性分析。
Zotero 插件